Linked e-resources
Details
Table of Contents
Part I. Introduction
Studies Linked to the Evolving HIV Epidemic in South Africa: Informing the CAPRISA Scientific Agenda
CAPRISA: Establishing A Research Center to Undertake HIV Clinical Trials
Overview of Clinical Trials
Part II. CAPRISA Clinical Trials for HIV and HSV-2 Prevention
Antiretrovirals for HIV Prevention
Rolling out of tenofovir gel in family planning clinics: the CAPRISA 008 implementation trial
Conditional cash transfers to reduce HIV risk in young women: the CAPRISA 007 cluster randomised control trial
HIV vaccine and passive immunity trials
Part III: CAPRISA Clinical Trials for HIV?TB Treatment
CAPRISA 003: Timing of antiretroviral initiation in HIV-TB co-infected patients
The SAPiT Trial
Scaling up TB-HIV integration in public health clinics: translating research findings into practice
Part IV: Experiences and lessons learnt from clinical trials in CAPRISA
Lessons from the Acute Infection Study: from Bench to Bedside
Understanding sexual HIV transmission in women by focusing on the genital mucosa
Part V: Essential support activities for the conduct of clinical trials
Good practices in conducting clinical trials: Good Participatory Practice, Good Pharmacy Practice and Good Laboratory Practice
Grants Management
Taking science to the people: communication and media strategies for clinical trials
Looking ahead: What Does the Future Hold for CAPRISA?
Appendix
Index. .
Studies Linked to the Evolving HIV Epidemic in South Africa: Informing the CAPRISA Scientific Agenda
CAPRISA: Establishing A Research Center to Undertake HIV Clinical Trials
Overview of Clinical Trials
Part II. CAPRISA Clinical Trials for HIV and HSV-2 Prevention
Antiretrovirals for HIV Prevention
Rolling out of tenofovir gel in family planning clinics: the CAPRISA 008 implementation trial
Conditional cash transfers to reduce HIV risk in young women: the CAPRISA 007 cluster randomised control trial
HIV vaccine and passive immunity trials
Part III: CAPRISA Clinical Trials for HIV?TB Treatment
CAPRISA 003: Timing of antiretroviral initiation in HIV-TB co-infected patients
The SAPiT Trial
Scaling up TB-HIV integration in public health clinics: translating research findings into practice
Part IV: Experiences and lessons learnt from clinical trials in CAPRISA
Lessons from the Acute Infection Study: from Bench to Bedside
Understanding sexual HIV transmission in women by focusing on the genital mucosa
Part V: Essential support activities for the conduct of clinical trials
Good practices in conducting clinical trials: Good Participatory Practice, Good Pharmacy Practice and Good Laboratory Practice
Grants Management
Taking science to the people: communication and media strategies for clinical trials
Looking ahead: What Does the Future Hold for CAPRISA?
Appendix
Index. .